Literature DB >> 4017168

Dose-response curves after in vivo experimental chemotherapy: influence of route of administration on biological outcomes.

J V Moore.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 4017168     DOI: 10.1007/bf00257514

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  4 in total

1.  Cell-cycle specificity and therapeutic effectiveness of cytostatic agents.

Authors:  L M Van Putten; P Lelieveld; L K Kram-Idsenga
Journal:  Cancer Chemother Rep       Date:  1972-12

2.  Differential effect of i.p.- and i.v.-injected adriamycin on the clonogenic spermatogonia of murine testis.

Authors:  J V Moore; J I Delic; J E Bentley
Journal:  Eur J Cancer Clin Oncol       Date:  1985-08

3.  Examination of the correlation of first-week mortality with the gastrointestinal syndrome following chemotherapy.

Authors:  J V Moore
Journal:  Cancer Treat Rep       Date:  1984 Jul-Aug

4.  Bleomycin and radiation-induced lung damage in mice.

Authors:  C H Collis; J D Down; A E Pearson; G G Steel
Journal:  Br J Radiol       Date:  1983-01       Impact factor: 3.039

  4 in total
  4 in total

1.  Pharmacokinetics in experimental and clinical chemotherapy.

Authors:  P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Effects of sodium cyanate in mice bearing B16 melanoma.

Authors:  M A Lea; A Luke; O Velazquez; L Carpenter; C F Martinson; H Z Hill; G J Hill
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  The relative toxicity of intravenous and intraperitoneal doses of epirubicin.

Authors:  T K Yeung; R H Simmonds; J W Hopewell
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Noninvasive routes of proteins and peptides drug delivery.

Authors:  P K Sharma; Sumedha Bansal; Arunabha Banik
Journal:  Indian J Pharm Sci       Date:  2011-07       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.